Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination
Advanced Science · 2025
DOI: 10.1002/advs.202411320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Weimin Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200092, China. Hauptthemen laut MEDLINE: Oxidative Stress, NF-E2-Related Factor 2, Colitis, Ubiquitin-Specific Peptidase 7. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Interdisciplinary Program of Shanghai Jiaotong University, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is associated with oxidative stress and redox signaling disruption. It is recently reported that proautophagic autophagy/beclin‐1 regulator 1 (AMBRA1) is a positive modulator of the NF‐κB pathway that promotes intestinal inflammation. However, its effect on intestinal redox state and whether AMBRA1 is regulated by oxidative stress remain unknown. In this study, it is found that AMBRA1 functions as a pro‐oxidative factor that increases oxidative stress in intestinal epithelial cells (IECs) in vitro and in vivo. Mechanistically, the N‐terminal F1 domain is required for AMBRA1 to competitively interact with the N‐terminal domain of NRF2, thereby antagonizing the interaction between deubiquitinating protein 3 (DUB3) and NRF2, suppressing DUB3‐mediated NRF2 deubiquitination, and leading to NRF2 degradation. In response to H 2 O 2 stimulation, the interaction between AMBRA1 and ubiquitin‐specific protease 7 (USP7) is enhanced, facilitating USP7 to deubiquitinate AMBRA1 at K83 and K86 and stabilize AMBRA1. Notably, the USP7 inhibitor, P5091, inhibits oxidative stress and colitis in vivo. Elevated AMBRA1 expression in inflamed colon tissues from ulcerative colitis patients is negatively correlated with decreased NRF2 protein levels. Overall, this study identifies AMBRA1 as a pro‐oxidative factor in IECs and provides a redox‐modulating therapeutic strategy for targeting USP7/AMBRA1 in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200092, China.
- Shanghai Colorectal Cancer Research Center, Shanghai, 200092, China.
- Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200092, China.
- Department of Gastroenterology, Rui Jin Hospital, Affiliate to Shanghai Jiao Tong University, school of Medicine, 197 Rui Jin Er Road, Shanghai, 200025, China.
ORCID-Profile: Peng Du
Förderung
- Interdisciplinary Program of Shanghai Jiaotong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Hospital Deveopment Center
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Xu, W., Hua, Z., Wang, Y., Tang, W., Ge, W., Chen, Y., Wang, Z., Gu, Y., Liu, C. Y., & Du, P. (2025). Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination. Advanced Science. https://doi.org/10.1002/advs.202411320
Vancouver
Xu W, Hua Z, Wang Y, Tang W, Ge W, Chen Y, et al. Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination. Advanced Science. 2025. doi:10.1002/advs.202411320
BibTeX
@article{Xu2025,
author = {Xu, Weimin and Hua, Zhebin and Wang, Yaosheng and Tang, Wenbo and Ge, Wensong and Chen, YingWei and Wang, Zhongchuan and Gu, Yubei and Liu, Chen-Ying and Du, Peng},
title = {Redox‐Induced Stabilization of AMBRA1 by USP7 Promotes Intestinal Oxidative Stress and Colitis Through Antagonizing DUB3‐Mediated NRF2 Deubiquitination},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411320}
}
EUVIMED